By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Relmada Therapeutics 

  New York    U.S.A.
Phone: n/a Fax: n/a


Company News
Relmada Therapeutics Completes Name Change And Announces New Ticker 8/6/2014 9:03:55 AM
Camp Nine Inc. Announces Corporate Name Change To Relmada Therapeutics 7/9/2014 9:30:01 AM
Relmada Therapeutics Files Shares Registration Statement 7/1/2014 10:04:30 AM
Relmada Therapeutics To Present At The 2014 Biotechnology Industry Organization (BIO) International Convention 6/19/2014 7:38:35 AM
Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million In Connection With Going Public Transaction 6/16/2014 6:40:18 AM
Relmada Therapeutics Appoints Douglas J. Beck As Chief Financial Officer 12/11/2013 6:21:32 AM
Relmada Therapeutics Completes $8 Million Capital Raise in Series A Financing 10/1/2013 6:35:56 AM
Relmada Therapeutics Announces Collaboration With the Malvern Consulting Group 9/16/2013 9:58:05 AM
Relmada Therapeutics Announces Positive Results of LevoCap ER Pivotal Pharmacokinetic Study 9/10/2013 7:34:41 AM